02:14:49 EDT Wed 15 May 2024
Enter Symbol
or Name
USA
CA



Anaergia Inc
Symbol ANRG
Shares Issued 29,148,495
Close 2023-08-14 C$ 1.15
Market Cap C$ 33,520,769
Recent Sedar Documents

Anaergia loses $119.8-million in Q2

2023-08-14 20:02 ET - News Release

Ms. Melissa Bailey reports

ANAERGIA REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS

Anaergia Inc. has released its financial results for the three- and six-month periods ended June 30, 2023 (Q2 2023), and the related management's discussion and analysis (MD&A) for the period. Certain highlights from these financial results and from the MD&A follow. All financial results are reported in Canadian dollars unless otherwise stated.

Rialto Bioenergy Facility LLC (the RBF) update

As previously disclosed, the RBF voluntarily entered into Chapter 11. The facility is facing a shortfall in feedstock supply primarily due to delayed implementation and enforcement of laws requiring organic waste diversion from landfills by the City of Los Angeles as required under the city's contracts with private waste management companies as well as under California state law SB1383. Anaergia anticipates that if and when regulation is enforced, future feedstock for the RBF will increase and, with additional time and relief from debt service and other payments provided under a Chapter 11 restructuring to allow ramp-up, the long-term value will be improved for all stakeholders.

As part of the continuing restructuring process, a key milestone is the outcome of the court proceedings in August, 2023, concerning a dispute over valuation. The result of this court process will clarify potential outcomes of the restructuring.

The company has ceased control of the RBF from an accounting perspective during the restructuring process and is no longer consolidating the RBF on its consolidated financial statements. As previously disclosed, Anaergia had been supporting the RBF with loans or equity contributions to address liquidity challenges but will no longer be providing financial support to the RBF during the restructuring process.

Other notable developments:

  • Anaergia is currently undergoing a strategic review of the company's options to maximize shareholder value.
  • As further discussed in the MD&A, the company notes the possible implications of a lender option relating to the loan for the build-own-operate assets in Italy, which allows the lender to require purchase of the loan by Anaergia, if certain conditions are not met.
  • The financial statements have been prepared in accordance with IFRS (international financial reporting standards), which contemplates continuation of the company as a going concern. However, the company's operating performance has not generated the positive cash flows required to maintain its business as a going concern without access to external sources of capital.

Financial results for the first half of fiscal 2023

Six-month financial highlights:

  • Revenues increased 1.5 per cent or $1.2-million to $79.1-million compared with the same period in fiscal 2022 (Q2 2022: $77.9-million). The increase was driven mainly by increased revenue in the build-own-operate segment, offset by a decline in the capital sales segment.
  • Net loss of $131.0-million increased 299.6 per cent or $98.2-million compared with the same period in fiscal 2022 (Q2 2022: net loss of $32.8-million). The increase was mainly due to a loss of $37.9-million related to the deconsolidation of the RBF during Q2 2023 and a total estimated credit loss expense taken during the quarter of $59.4-million, which included a loss of $54.6-million on certain loans that were no longer deemed recoverable during the company's continuing strategic review, including discussions with lenders.
  • Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) (1) decreased 232.9 per cent or $13.2-million to a loss of $18.9-million compared with the same period in fiscal 2022 (Q2 2022: loss of $5.7-million). The decrease was due to a decline in gross profit and increased operating expenses.

For a more detailed discussion of Anaergia's results for Q2 2023, please see the company's financial statements for Q2 2023 and related MD&A, which are available on the company's SEDAR+ page.

Fiscal 2023 guidance withdrawn

Anaergia, in prior periods, has provided guidance regarding its projected revenue and adjusted EBITDA for fiscal 2023, which was based on it having adequate liquidity and access to capital in order to execute its plans. In light of a number of factors, including the continued deterioration of the company's financial performance (as reflected in the reported net losses and negative operating cash flows), weakened liquidity position, recent changes to senior management and the continuing strategic review, the company now believes it will not achieve the estimates included in previous guidance and expects such measures of revenue and adjusted EBITDA to be lower than previously guided. Accordingly, management has withdrawn the company's previously disclosed fiscal 2023 guidance.

Management will not be able to provide any updates regarding guidance, including projected revenue and adjusted EBITDA, until the completion of the company's strategic review and a reassessment of assumptions related thereto.

Non-IFRS measures

This news release makes reference to certain non-IFRS measures. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable with similar measures presented by other companies. Rather, these measures are provided as additional information to complement IFRS measures by providing further understanding of the company's results of operations from management's perspective. Accordingly, these measures should not be considered in isolation or as a substitute for analysis of the company's financial information reported under IFRS. The company uses non-IFRS measures to provide investors with supplemental measures. Management also uses non-IFRS measures internally in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets, and assess the company's ability to meet its future debt service, capital expenditure and working capital requirements. Management believes these non-IFRS measures and industry metrics are important supplemental measures of operating performance because they eliminate items that have less bearing on operating performance and highlight trends in the core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management believes such measures allow for assessment of the company's operating performance and financial condition on a basis that is more consistent and comparable between reporting periods. It also believes that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of public companies.

(1) Adjusted EBITDA is defined as net earnings before finance costs, taxes, and depreciation and amortization, adjusted for the company's normalized proportionate interest in its BOO assets and one-time or non-recurring items, stock-based compensation expense, asset impairment charges and writedowns, gains and losses for equity-accounted investees, foreign exchange gains or losses, restructuring costs, ERP customization and configuration costs, litigation and other claims settlements, gains and losses resulting from changes in certain balance sheet valuations (such as derivatives and warrants), acquisition costs, and costs related to its initial public offering, including estimated incremental auditing and professional services costs incurred in connection with its initial public offering.

Conference call and webcast details

A conference call to review the company's financial results will take place at 9 a.m. ET on Tuesday, Aug. 15, 2023. It will be hosted by management of Anaergia. An accompanying slide presentation will be posted to the investor relations section of the company's website shortly before the call.

To participate on the call, please preregister on-line to receive details on how to access the conference call.

You will receive your access details via e-mail. A live webcast will be available. The webcast will be archived and available in the investor relations section of the company's website following the call.

About Anaergia Inc.

Anaergia was created to eliminate a major source of greenhouse gases by cost-effectively turning organic waste into renewable natural gas (RNG), fertilizer and water, using proprietary technologies. With a proven record from delivering world-leading projects on four continents, Anaergia is uniquely positioned to provide end-to-end solutions for extracting organics from waste, implementing high-efficiency anaerobic digestion, upgrading biogas, producing fertilizer and cleaning water. Its customers are in the municipal solid waste, municipal waste water, agriculture and food processing industries. In each of these markets, Anaergia has built many successful plants, including some of the largest in the world. Anaergia owns and operates some of the plants it builds, and it also operates plants that are owned by its customers.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.